We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.
- Authors
Mehta, A; Ricci, R; Widmer, U; Dehout, F; Garcia de Lorenzo, A; Kampmann, C; Linhart, A; Sunder-Plassmann, G; Ries, M; Beck, M
- Abstract
Fabry disease is a rare X-linked disorder caused by deficient activity of the lysosomal enzyme alpha-galactosidase A. Progressive accumulation of the substrate globotriaosylceramide in cells throughout the body leads to major organ failure and premature death. In response to the recent introduction of enzyme replacement therapy, the Fabry Outcome Survey (FOS) was established to pool data from European clinics on the natural history of this little-known disease and to monitor the long-term efficacy and safety of treatment. This paper presents the first analysis of the FOS database and provides essential baseline data against which the effects of enzyme replacement can be measured.
- Publication
European journal of clinical investigation, 2004, Vol 34, Issue 3, p236
- ISSN
0014-2972
- Publication type
Journal Article
- DOI
10.1111/j.1365-2362.2004.01309.x